These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24836329)

  • 1. Osteoporosis and fragility fractures. Preface.
    Marsh D; Woolf A; Akesson K
    Best Pract Res Clin Rheumatol; 2013 Dec; 27(6):709-10. PubMed ID: 24836329
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
    Aubry-Rozier B; Gonzalez-Rodriguez E; Stoll D; Lamy O
    Osteoporos Int; 2016 May; 27(5):1923-5. PubMed ID: 26510845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can we influence the incidence of secondary fragility fractures? A review on current approaches.
    Pape HC; Bischoff-Ferrari HA
    Injury; 2017 Dec; 48 Suppl 7():S24-S26. PubMed ID: 28870622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive approach to fragility fractures.
    Rebolledo BJ; Unnanuntana A; Lane JM
    J Orthop Trauma; 2011 Sep; 25(9):566-73. PubMed ID: 21654529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the role of the orthopaedic surgeon in management of fragility fractures?
    Sharif KM; Dimitriou R; Giannoudis PV
    J Orthop Trauma; 2011 Jun; 25 Suppl 2():S47-50. PubMed ID: 21566474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male osteoporosis: who should be treated and how?
    Biver E; Borg S; Chopin F; Hoppé E; Morel G; Cortet B
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S202-7. PubMed ID: 22153671
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of male osteoporosis: lessons for clinical practice.
    Cortet B; Biver E; Borg S; Chopin F; Hoppé E; Laroche M; Morel G; Razjbaum G; Roux C; Thomas T; Legrand E
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S208-10. PubMed ID: 22153672
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention and rehabilitation of osteoporosis.
    Kerschan-Schindl K
    Wien Med Wochenschr; 2016 Feb; 166(1-2):22-7. PubMed ID: 26769298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in osteoporosis management: how do you treat a newly menopausal woman with low bone mass: when and how is it appropriate to provide pharmacologic intervention to prevent osteoporosis?
    Jiang X; Kagan R; Schnatz PF
    Clin Obstet Gynecol; 2013 Dec; 56(4):739-42. PubMed ID: 24022501
    [No Abstract]   [Full Text] [Related]  

  • 10. [Osteoporosis].
    Uelbelhart B; Rizzoli R
    Rev Med Suisse; 2012 Jan; 8(324):109-10, 112-5. PubMed ID: 23185820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporotic Fracture Program management: who should be in charge? A comparative survey of knowledge in orthopaedic surgeons and internists.
    Sorbi R; Aghamirsalim M
    Orthop Traumatol Surg Res; 2013 Oct; 99(6):723-30. PubMed ID: 23849486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of osteoporosis and the surgeons' role.
    Rosenwasser MP; Cuellar D
    Injury; 2016 Jan; 47 Suppl 1():S62-4. PubMed ID: 26768294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
    Col NF; Bowlby LA; McGarry K
    Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].
    Eiken PA; Abrahamsen B
    Ugeskr Laeger; 2009 Mar; 171(11):903-6. PubMed ID: 19278615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Promises and fears of osteoporosis treatments].
    Uebelhart B
    Rev Med Suisse; 2013 Jan; 9(371):262. PubMed ID: 23451595
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for osteoporosis.
    Croswell J
    Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monthly tablet in postmenopausal osteoporosis].
    Krankenpfl J; 2005; 43(7-10):216. PubMed ID: 16515288
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for osteoporosis: recommendation statement.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2011 May; 83(10):1197-200. PubMed ID: 21568254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S
    Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium pros and cons: long term use of bisphosphonates. Bisphophonate should not be used for long term].
    Mori S
    Clin Calcium; 2011 Oct; 21(10):1547-51. PubMed ID: 21960243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.